Top

Published in:

01-08-2012 | Nephrology – Original Paper

Risk factors for depressive symptoms in a large population on chronic hemodialysis

Authors: Sônia M. H. A. Araujo, Veralice M. S. de Bruin, Elizabeth de F. Daher, Gilson H. Almeida, Camila A. M. Medeiros, Pedro Felipe C. de Bruin

Published in: International Urology and Nephrology | Issue 4/2012

Abstract

Despite their significant influence on the quality of life, depressive symptoms are not usually included as a clinical parameter in the evaluation of hemodialysis patients. We aimed to identify depressive symptoms and associated risk factors in a large group of individuals with end-stage renal disease (ESRD) on chronic hemodialysis. This was a cross-sectional study of 400 consecutive patients. Cases were analyzed according to the presence/absence of depressive symptoms. All individuals were investigated by interview, and all variables were measured concurrently. Depressive symptoms were evaluated by the Beck Depression Inventory (BDI-II ≥16) and sleep quality by the Pittsburgh Sleep Quality Index (PSQI > 5). Among the 400 patients (59% male), depressive symptoms were present in 77 (19.3%). Depressive symptoms were more common in women and were independently associated with poor sleep quality (P = <0.005), unemployment (P = 0.001), diabetes (P = 0.02), hypoalbuminemia (P = 0.01), low education (P = 0.03), and pruritus (P = 0.04). Women with ESRD on chronic hemodialysis are at increased risk of depression. Furthermore, unemployment and the presence of diabetes, hypoalbuminemia, low education, and pruritus are significantly associated with depressive symptoms. Depressive symptoms are also independently associated with poor quality sleep and studies about the effects of sleep hygiene therapy on depressive symptoms are warranted.

Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, Mapes DL, Mason NA, Fukuhara S, Wikstrom B, Saito A, Port FK (2004) Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 66:2047–2053PubMedCrossRef

Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK (2002) Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 62:199–207PubMedCrossRef

Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, Powe NR (2006) Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 1:496–504PubMedCrossRef

Hedayati SS, Bosworth HB, Briley LP, Sloane RJ, Pieper CF, Kimmel PL, Szczech LA (2008) Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int 74:930–936PubMedCrossRef

Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH (2000) Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 57:2093–2098PubMedCrossRef

Bossola M, Ciciarelli C, Conte GL, Vulpio C, Luciani G, Tazza L (2010) Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Gen Hosp Psychiatry 32:125–131PubMedCrossRef

Cruz LN, de Almeida Fleck MP, Polanczyk CA (2010) Depression as a determinant of quality of life in patients with chronic disease: data from Brazil. Soc Psychiatry Psychiatr Epidemiol 45:953–961PubMedCrossRef

Daneker B, Kimmel PL, Ranich T, Peterson RA (2001) Depression and marital dissatisfaction in patients with end-stage renal disease and in their spouses. Am J Kidney Dis 38:839–846PubMedCrossRef

Johnson S, Dwyer A (2008) Patient perceived barriers to treatment of depression and anxiety in hemodialysis patients. Clin Nephrol 69:201–206PubMed

10.

Riezebos RK, Nauta KJ, Honig A, Dekker FW, Siegert CE (2010) The association of depressive symptoms with survival in a Dutch cohort of patients with end-stage renal disease. Nephrol Dial Transplant 25:231–236PubMedCrossRef

11.

Spencer BW, Chilcot J, Farrington K (2011) Still sad after successful renal transplantation: are we failing to recognise depression? An audit of depression screening in renal graft recipients. Nephron Clin Pract 117:c106–c112PubMedCrossRef

12.

Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287–2300PubMedCrossRef

13.

Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M (2007) Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 17:381–388PubMedCrossRef

14.

Chen CK, Tsai YC, Hsu HJ, Wu IW, Sun CY, Chou CC, Lee CC, Tsai CR, Wu MS, Wang LJ (2010) Depression and suicide risk in hemodialysis patients with chronic renal failure. Psychosomatics 51:528 e526PubMed

15.

Araujo SM, de Bruin VM, Nepomuceno LA, Maximo ML, Daher Ede F, Correia Ferrer DP, de Bruin PF (2010) Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 11:785–790PubMedCrossRef

16.

Dawson DA, Grant BF, Li TK (2005) Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res 29:902–908PubMedCrossRef

17.

Kaveh K, Kimmel PL (2001) Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis 37:244–266PubMedCrossRef

18.

Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck depression inventory. J Clin Psychol 40:1365–1367PubMedCrossRef

19.

Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA (2006) The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 69:1662–1668PubMedCrossRef

20.

Chilcot J, Wellsted D, Farrington K (2008) Screening for depression while patients dialyse: an evaluation. Nephrol Dial Transplant 23:2653–2659PubMedCrossRef

21.

Gorenstein C, Andrade L, Vieira Filho AH, Tung TC, Artes R (1999) Psychometric properties of the Portuguese version of the Beck depression inventory on Brazilian college students. J Clin Psychol 55:553–562PubMedCrossRef

22.

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRef

23.

van Steenbergen-Weijenburg KM, van Puffelen AL, Horn EK, Nuyen J, van Dam PS, van Benthem TB, Beekman AT, Rutten FF, Hakkaart-van Roijen L, van der Feltz-Cornelis CM (2011) More co-morbid depression in patients with type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic. Diabet Med 28:86–89PubMedCrossRef

24.

Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Willett WC, Manson JE, Rexrode KM, Ascherio A, Hu FB (2011) Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 68:42–50PubMedCrossRef

25.

Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O (2007) Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract 61:569–576PubMedCrossRef

26.

Simic Ogrizovic S, Jovanovic D, Dopsaj V, Radovic M, Sumarac Z, Bogavac SN, Stosovic M, Stanojevic M, Nesic V (2009) Could depression be a new branch of MIA syndrome? Clin Nephrol 71:164–172PubMed

27.

Huang TL, Lee CT (2007) Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression. Psychiatry Res 152:277–280PubMedCrossRef

28.

Ibrahim S, El Salamony O (2008) Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol 28:784–791PubMedCrossRef

29.

Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31PubMedCrossRef

30.

da Silva AM, Vilhena E, Lopes A, Santos E, Goncalves MA, Pinto C, Moreira I, Mendonca D, Cavaco S (2011) Depression and anxiety in a Portuguese MS population: Associations with physical disability and severity of disease. J Neurol Sci (Epub)

31.

Murtagh FE, Addington-Hall J, Higginson IJ (2007) The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 14:82–99

32.

Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK (2006) Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 21:3495–3505PubMedCrossRef

33.

Kimmel PL, Cohen SD, Weisbord SD (2008) Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough!. J Nephrol 21(Suppl 13):S54–S58PubMed

34.

Yamamoto Y, Hayashino Y, Yamazaki S, Akiba T, Akizawa T, Asano Y, Saito A, Kurokawa K, Miyachi Y, Fukuhara S (2009) Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study. Br J Dermatol 161:384–389PubMedCrossRef

35.

Bornivelli C, Alivanis P, Giannikouris I, Arvanitis A, Choustoulakis I, Georgopoulou K, Karvouniaris N, Zervos A (2008) Relation between insomnia mood disorders and clinical and biochemical parameters in patients undergoing chronic hemodialysis. J Nephrol 21(Suppl 13):S78–S83PubMed

36.

Sabry AA, Abo-Zenah H, Wafa E, Mahmoud K, El-Dahshan K, Hassan A, Abbas TM, Saleh Ael B, Okasha K (2010) Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl 21:300–305PubMed

37.

Parker KP (2003) Sleep disturbances in dialysis patients. Sleep Med Rev 7:131–143PubMedCrossRef

38.

Ong JC, Gress JL, San Pedro-Salcedo MG, Manber R (2009) Frequency and predictors of obstructive sleep apnea among individuals with major depressive disorder and insomnia. J Psychosom Res 67:135–141PubMedCrossRef

39.

Watnick S, Wang PL, Demadura T, Ganzini L (2005) Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis 46:919–924PubMedCrossRef

40.

Craven JL, Rodin GM, Littlefield C (1988) The Beck depression inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 18:365–374PubMedCrossRef

41.

Walters BA, Hays RD, Spritzer KL, Fridman M, Carter WB (2002) Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis 40:1185–1194PubMedCrossRef

42.

Watnick S, Kirwin P, Mahnensmith R, Concato J (2003) The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 41:105–110PubMedCrossRef

43.

Hedayati SS, Finkelstein FO (2009) Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 54:741–752PubMedCrossRef

44.

Finkelstein FO, Wuerth D, Troidle LK, Finkelstein SH (2008) Depression and end-stage renal disease: a therapeutic challenge. Kidney Int 74:843–845PubMedCrossRef

45.

Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL (2007) Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2:1332–1342PubMedCrossRef

46.

Kimmel PL, Weihs K, Peterson RA (1993) Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 4:12–27PubMed

Title: Risk factors for depressive symptoms in a large population on chronic hemodialysis
Authors: Sônia M. H. A. Araujo
Veralice M. S. de Bruin
Elizabeth de F. Daher
Gilson H. Almeida
Camila A. M. Medeiros
Pedro Felipe C. de Bruin
Publication date: 01-08-2012
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 4/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-011-0032-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990–1991 and 2009–2010

Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival

Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients

Quality of life and protein-energy wasting in kidney transplant recipients

Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients

Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials